Asia Pacific Donor Blood Component Market Analysis and Forecast by Size, Share, Growth, Trends 2031
Asia Pacific Donor Blood Component Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Blood Component (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Blood Component Volume (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Indication (Immunosuppression and Oncology), Immunosuppression (Organ Transplant, HIV or AIDS, Autoimmune Disease, Cardiovascular Surgeries, Orthopedic Surgeries, and Others), Oncology (Hematologic Malignancies and Solid Tumor Patients), Application (Anemia Management, Thrombocytopenia Treatment, Coagulopathy Correction, Supportive Care during Chemotherapy, Surgery, and Others), Age Group (Adult and Child), and End User (Hospitals, Oncology Centers, Transplant Centers, Ambulatory Surgical Centers, and Others)
- Status : Published
- Report Code : TIPRE00041956
- Category : Life Sciences
- No. of Pages : 189
- Available Report Formats :
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. Donor Blood Component Market Landscape
4.1 Market Overview
4.2 PEST Analysis
4.3 Average Selling Price Per Unit (US$) of Blood Components, 2024
4.4 Global Disease Prevalence of 5 Key Diseases, 2024
5. Asia Pacific Donor Blood Component Market - Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. Donor Blood Component Market - Asia Pacific Market Analysis
6.1 Asia Pacific Donor Blood Component Market Revenue (US$ Million), 2024 - 2031
6.2 Asia Pacific Donor Blood Component Market Forecast and Analysis
7. Asia Pacific Donor Blood Component Market Revenue Analysis - by Blood Component
7.1 Red Blood Cells
7.1.1 Overview
7.1.2 Red Blood Cells: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 White blood cells
7.2.1 Overview
7.2.2 White blood cells: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Platelets
7.3.1 Overview
7.3.2 Platelets: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Plasma
7.4.1 Overview
7.4.2 Plasma: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. Asia Pacific Donor Blood Component Market Revenue Analysis - by Blood Component Volume
8.1 Red Blood Cells
8.1.1 Overview
8.1.2 Red Blood Cells: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 White blood cells
8.2.1 Overview
8.2.2 White blood cells: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Platelets
8.3.1 Overview
8.3.2 Platelets: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4 Plasma
8.4.1 Overview
8.4.2 Plasma: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. Asia Pacific Donor Blood Component Market Revenue Analysis - by Indication
9.1 Immunosuppression
9.1.1 Overview
9.1.2 Immunosuppression: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Oncology
9.2.1 Overview
9.2.2 Oncology: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. Asia Pacific Donor Blood Component Market Revenue Analysis - by Immunosuppression
10.1 Organ Transplant
10.1.1 Overview
10.1.2 Organ Transplant: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 HIV or AIDS
10.2.1 Overview
10.2.2 HIV or AIDS: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Autoimmune Disease
10.3.1 Overview
10.3.2 Autoimmune Disease: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.4 Cardiovascular Surgeries
10.4.1 Overview
10.4.2 Cardiovascular Surgeries: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.5 Orthopedic Surgeries
10.5.1 Overview
10.5.2 Orthopedic Surgeries: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. Asia Pacific Donor Blood Component Market Revenue Analysis - by Oncology
11.1 Hematologic malignancies
11.1.1 Overview
11.1.2 Hematologic malignancies: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2 Solid Tumor Patients
11.2.1 Overview
11.2.2 Solid Tumor Patients: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12. Asia Pacific Donor Blood Component Market Revenue Analysis - by Application
12.1 Anemia management
12.1.1 Overview
12.1.2 Anemia management: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.2 Thrombocytopenia treatment
12.2.1 Overview
12.2.2 Thrombocytopenia treatment: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.3 Coagulopathy correction
12.3.1 Overview
12.3.2 Coagulopathy correction: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.4 Supportive care during chemotherapy
12.4.1 Overview
12.4.2 Supportive care during chemotherapy: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.5 Surgery
12.5.1 Overview
12.5.2 Surgery: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.6 Others
12.6.1 Overview
12.6.2 Others: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13. Asia Pacific Donor Blood Component Market Revenue Analysis - by Age Group
13.1 Adult
13.1.1 Overview
13.1.2 Adult: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.2 Child
13.2.1 Overview
13.2.2 Child: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14. Asia Pacific Donor Blood Component Market Revenue Analysis - by End User
14.1 Hospitals
14.1.1 Overview
14.1.2 Hospitals: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.2 Oncology centers
14.2.1 Overview
14.2.2 Oncology centers: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.3 Transplant centers
14.3.1 Overview
14.3.2 Transplant centers: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.4 Ambulatory surgical centers
14.4.1 Overview
14.4.2 Ambulatory surgical centers: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.5 Others
14.5.1 Overview
14.5.2 Others: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15. Asia Pacific Donor Blood Component Market - Country Analysis
15.1 Asia Pacific
15.1.1 Asia Pacific Donor Blood Component Market Revenue and Forecast and Analysis - by Country
15.1.1.1 Asia Pacific Donor Blood Component Market Revenue and Forecast and Analysis - by Country
15.1.2.2 China: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.1.2.2.1 China: Asia Pacific Donor Blood Component Market Share - by Blood Component
15.1.2.2.2 China: Asia Pacific Donor Blood Component Market Share - by Blood Component Volume
15.1.2.2.3 China: Asia Pacific Donor Blood Component Market Share - by Indication
15.1.2.2.4 China: Asia Pacific Donor Blood Component Market Share - by Immunosuppression
15.1.2.2.5 China: Asia Pacific Donor Blood Component Market Share - by Oncology
15.1.2.2.6 China: Asia Pacific Donor Blood Component Market Share - by Application
15.1.2.2.7 China: Asia Pacific Donor Blood Component Market Share - by Age Group
15.1.2.2.8 China: Asia Pacific Donor Blood Component Market Share - by End User
15.2.3.3 Japan: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.2.3.3.1 Japan: Asia Pacific Donor Blood Component Market Share - by Blood Component
15.2.3.3.2 Japan: Asia Pacific Donor Blood Component Market Share - by Blood Component Volume
15.2.3.3.3 Japan: Asia Pacific Donor Blood Component Market Share - by Indication
15.2.3.3.4 Japan: Asia Pacific Donor Blood Component Market Share - by Immunosuppression
15.2.3.3.5 Japan: Asia Pacific Donor Blood Component Market Share - by Oncology
15.2.3.3.6 Japan: Asia Pacific Donor Blood Component Market Share - by Application
15.2.3.3.7 Japan: Asia Pacific Donor Blood Component Market Share - by Age Group
15.2.3.3.8 Japan: Asia Pacific Donor Blood Component Market Share - by End User
15.3.4.4 India: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.3.4.4.1 India: Asia Pacific Donor Blood Component Market Share - by Blood Component
15.3.4.4.2 India: Asia Pacific Donor Blood Component Market Share - by Blood Component Volume
15.3.4.4.3 India: Asia Pacific Donor Blood Component Market Share - by Indication
15.3.4.4.4 India: Asia Pacific Donor Blood Component Market Share - by Immunosuppression
15.3.4.4.5 India: Asia Pacific Donor Blood Component Market Share - by Oncology
15.3.4.4.6 India: Asia Pacific Donor Blood Component Market Share - by Application
15.3.4.4.7 India: Asia Pacific Donor Blood Component Market Share - by Age Group
15.3.4.4.8 India: Asia Pacific Donor Blood Component Market Share - by End User
15.4.5.5 Australia: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.4.5.5.1 Australia: Asia Pacific Donor Blood Component Market Share - by Blood Component
15.4.5.5.2 Australia: Asia Pacific Donor Blood Component Market Share - by Blood Component Volume
15.4.5.5.3 Australia: Asia Pacific Donor Blood Component Market Share - by Indication
15.4.5.5.4 Australia: Asia Pacific Donor Blood Component Market Share - by Immunosuppression
15.4.5.5.5 Australia: Asia Pacific Donor Blood Component Market Share - by Oncology
15.4.5.5.6 Australia: Asia Pacific Donor Blood Component Market Share - by Application
15.4.5.5.7 Australia: Asia Pacific Donor Blood Component Market Share - by Age Group
15.4.5.5.8 Australia: Asia Pacific Donor Blood Component Market Share - by End User
15.5.6.6 South Korea: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.5.6.6.1 South Korea: Asia Pacific Donor Blood Component Market Share - by Blood Component
15.5.6.6.2 South Korea: Asia Pacific Donor Blood Component Market Share - by Blood Component Volume
15.5.6.6.3 South Korea: Asia Pacific Donor Blood Component Market Share - by Indication
15.5.6.6.4 South Korea: Asia Pacific Donor Blood Component Market Share - by Immunosuppression
15.5.6.6.5 South Korea: Asia Pacific Donor Blood Component Market Share - by Oncology
15.5.6.6.6 South Korea: Asia Pacific Donor Blood Component Market Share - by Application
15.5.6.6.7 South Korea: Asia Pacific Donor Blood Component Market Share - by Age Group
15.5.6.6.8 South Korea: Asia Pacific Donor Blood Component Market Share - by End User
15.6.7.7 Rest of APAC: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.6.7.7.1 Rest of APAC: Asia Pacific Donor Blood Component Market Share - by Blood Component
15.6.7.7.2 Rest of APAC: Asia Pacific Donor Blood Component Market Share - by Blood Component Volume
15.6.7.7.3 Rest of APAC: Asia Pacific Donor Blood Component Market Share - by Indication
15.6.7.7.4 Rest of APAC: Asia Pacific Donor Blood Component Market Share - by Immunosuppression
15.6.7.7.5 Rest of APAC: Asia Pacific Donor Blood Component Market Share - by Oncology
15.6.7.7.6 Rest of APAC: Asia Pacific Donor Blood Component Market Share - by Application
15.6.7.7.7 Rest of APAC: Asia Pacific Donor Blood Component Market Share - by Age Group
15.6.7.7.8 Rest of APAC: Asia Pacific Donor Blood Component Market Share - by End User
17 Industry Landscape
17.1 Overview
17.2 New Product Development
17.3 Merger and Acquisition
17.4 Other Strategic Developments
18 COMPANY PROFILES
18.1 Vitalant
18.1.1 Key Facts
18.1.2 Business Description
18.1.3 Products and Services
18.1.4 Financial Overview
18.1.5 SWOT Analysis
18.1.6 Key Developments
18.2 Memorial Sloan Kettering Cancer Center
18.2.1 Key Facts
18.2.2 Business Description
18.2.3 Products and Services
18.2.4 Financial Overview
18.2.5 SWOT Analysis
18.2.6 Key Developments
18.3 Roswell Park Comprehensive Cancer Center
18.3.1 Key Facts
18.3.2 Business Description
18.3.3 Products and Services
18.3.4 Financial Overview
18.3.5 SWOT Analysis
18.3.6 Key Developments
18.4 Policlinico of Milan
18.4.1 Key Facts
18.4.2 Business Description
18.4.3 Products and Services
18.4.4 Financial Overview
18.4.5 SWOT Analysis
18.4.6 Key Developments
18.5 MD Anderson Cancer Center.
18.5.1 Key Facts
18.5.2 Business Description
18.5.3 Products and Services
18.5.4 Financial Overview
18.5.5 SWOT Analysis
18.5.6 Key Developments
18.6 The Johns Hopkins Hospital
18.6.1 Key Facts
18.6.2 Business Description
18.6.3 Products and Services
18.6.4 Financial Overview
18.6.5 SWOT Analysis
18.6.6 Key Developments
18.7 The Royal Marsden
18.7.1 Key Facts
18.7.2 Business Description
18.7.3 Products and Services
18.7.4 Financial Overview
18.7.5 SWOT Analysis
18.7.6 Key Developments
18.8 Gustave Roussy
18.8.1 Key Facts
18.8.2 Business Description
18.8.3 Products and Services
18.8.4 Financial Overview
18.8.5 SWOT Analysis
18.8.6 Key Developments
18.9 Peter MacCallum Cancer Centre
18.9.1 Key Facts
18.9.2 Business Description
18.9.3 Products and Services
18.9.4 Financial Overview
18.9.5 SWOT Analysis
18.9.6 Key Developments
18.10 Tata Memorial Hospital
18.10.1 Key Facts
18.10.2 Business Description
18.10.3 Products and Services
18.10.4 Financial Overview
18.10.5 SWOT Analysis
18.10.6 Key Developments
19. Appendix
19.1 About The Insight Partners
List of Tables
Table 1. Asia Pacific Donor Blood Component Market Segmentation
Table 3. Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 5. Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 6. Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 7. Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 8. Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 9. Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 10. Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 11. Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 12. Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 13. China: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 14. China: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 15. China: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 16. China: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 17. China: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 18. China: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 19. China: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 20. China: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 21. Japan: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 22. Japan: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 23. Japan: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 24. Japan: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 25. Japan: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 26. Japan: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 27. Japan: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 28. Japan: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 29. India: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 30. India: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 31. India: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 32. India: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 33. India: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 34. India: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 35. India: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 36. India: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 37. Australia: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 38. Australia: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 39. Australia: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 40. Australia: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 41. Australia: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 42. Australia: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 43. Australia: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 44. Australia: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 45. South Korea: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 46. South Korea: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 47. South Korea: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 48. South Korea: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 49. South Korea: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 50. South Korea: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 51. South Korea: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 52. South Korea: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 53. Rest of APAC: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 54. Rest of APAC: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 55. Rest of APAC: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 56. Rest of APAC: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 57. Rest of APAC: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 58. Rest of APAC: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 59. Rest of APAC: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 60. Rest of APAC: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
List of Figures
Figure 1. Asia Pacific Donor Blood Component Market Segmentation - Country
Figure 2. PEST Analysis
Figure 4. Asia Pacific Donor Blood Component Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Asia Pacific Donor Blood Component Market Revenue (US$ Million), 2024 - 2031
Figure 7. Asia Pacific Donor Blood Component Market Share (%) - by Blood Component, 2024 and 2031
Figure 8. Red Blood Cells: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. White blood cells: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Platelets: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Plasma: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Others: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Asia Pacific Donor Blood Component Market Share (%) - by Blood Component Volume, 2024 and 2031
Figure 14. Red Blood Cells: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. White blood cells: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Platelets: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Plasma: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Others: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Asia Pacific Donor Blood Component Market Share (%) - by Indication, 2024 and 2031
Figure 20. Immunosuppression: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Oncology: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. Asia Pacific Donor Blood Component Market Share (%) - by Immunosuppression, 2024 and 2031
Figure 23. Organ Transplant: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. HIV or AIDS: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Autoimmune Disease: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. Cardiovascular Surgeries: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Orthopedic Surgeries: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Others: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 29. Asia Pacific Donor Blood Component Market Share (%) - by Oncology, 2024 and 2031
Figure 30. Hematologic malignancies: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 31. Solid Tumor Patients: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. Asia Pacific Donor Blood Component Market Share (%) - by Application, 2024 and 2031
Figure 33. Anemia management: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 34. Thrombocytopenia treatment: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 35. Coagulopathy correction: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 36. Supportive care during chemotherapy: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 37. Surgery: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 38. Others: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 39. Asia Pacific Donor Blood Component Market Share (%) - by Age Group, 2024 and 2031
Figure 40. Adult: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 41. Child: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 42. Asia Pacific Donor Blood Component Market Share (%) - by End User, 2024 and 2031
Figure 43. Hospitals: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 44. Oncology centers: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 45. Transplant centers: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 46. Ambulatory surgical centers: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 47. Others: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 48. Asia Pacific Donor Blood Component Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 49. China: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 50. Japan: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 51. India: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 52. Australia: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 53. South Korea: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 54. Rest of APAC: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For